STAT August 11, 2020
Jordan Brayanov, Jen Goldsack and Bill Byrom

The biotech and pharma industries are at a pivotal moment, facing a pandemic that’s caused three out of every four clinical trials worldwide to be suspended or delayed. At the same time that hundreds of companies are racing to move forward with trials for Covid-19 treatments and vaccines, thousands more are worrying about how they’ll be able to conduct other trials in the midst of a global lockdown.

This is bad for business, and far worse for the patients afflicted by diseases and conditions whose drug trials have been sidelined for months.

Some companies are exploring remote clinical trials that rely on participants using digital devices like smartwatches and pulse oximeters at home. The approach makes sense, but there’s a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID, Technology, Wearables
Your Earphones And Headphones As Health And Medical Devices
Wearable Devices for Parkinson’s Disease: The Future Is Here
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Singapore tackling chronic diseases with wearables
Researchers use fitness tracker data and machine learning to detect bipolar disorder mood swings

Share This Article